| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |